David A. Esposito
Vorstandsvorsitzender bei Armune BioScience, Inc.
Profil
David A.
Esposito is the founder of Harvest Time Partners, Inc. He currently holds multiple positions including President, Chief Executive Officer & Director at Armune BioScience, Inc., President, Chief Executive Officer & Director at ONL Therapeutics, Inc., Director at Shield Diagnostics Corp., and Director at AllerGenis LLC.
Previously, he held positions such as Chairman at Medizone International, Inc., Principal at Merck & Co., Inc., Senior Vice President-Sales & Marketing at Phadia AB, Vice President-Commercial Operations at Thermo Fisher Scientific, Inc., and President at Phadia US, Inc. Esposito earned an MBA degree from Syracuse University and an undergraduate degree from US Military Academy.
Aktive Positionen von David A. Esposito
| Unternehmen | Position | Beginn |
|---|---|---|
Armune BioScience, Inc.
 Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Vorstandsvorsitzender | 01.01.2015 |
ONL Therapeutics, Inc.
 ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Vorstandsvorsitzender | 18.06.2019 |
Shield Diagnostics Corp.
 Shield Diagnostics Corp. Packaged SoftwareTechnology Services Shield Diagnostics Corp. develops advanced genotyping technologies for high throughput and high density testing. It offers beef and dairy cattle. The company was founded by Fred Turner and Sam Parlett and is headquartered in Santa Clara, CA. | Direktor/Vorstandsmitglied | 21.08.2019 |
AllerGenis LLC
 AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David A. Esposito
| Unternehmen | Position | Ende |
|---|---|---|
| MEDIZONE INTERNATIONAL, INC. | Vorstandsvorsitzender | 18.09.2017 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01.01.2013 |
Phadia US, Inc.
 Phadia US, Inc. BiotechnologyHealth Technology Part of Thermo Fisher Scientific, Inc., Phadia US, Inc. engages in the research and development of blood testing products and instrumentation that aid in the diagnosis of allergy. The company is based in Portage, MI. | Präsident | 01.01.2011 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2009 |
| Harvest Time Partners, Inc. | Gründer | - |
Ausbildung von David A. Esposito
| Syracuse University | Masters Business Admin |
| US Military Academy | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Medizone International, Inc.
 Medizone International, Inc. Medical SpecialtiesHealth Technology Medizone International, Inc. engages in the development and commercialization of AsepticSure system and provides disinfection solutions. AsepticSure system provides means of disinfecting non-porous surfaces in hospitals, healthcare facilities and other non- hospital facilities. It operates under the AsepticSure and Trioxidane brands. The company was founded in January 1986 and is headquartered in Kalamazoo, MI. | Health Technology |
Armune BioScience, Inc.
Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Health Services |
ONL Therapeutics, Inc.
ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |
Phadia AB
 Phadia AB Medical SpecialtiesHealth Technology Phadia AB develops, manufactures and markets blood test systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases. The company was founded in 2004 and is headquartered in Uppdala, Sweden. | Health Technology |
Phadia US, Inc.
Phadia US, Inc. BiotechnologyHealth Technology Part of Thermo Fisher Scientific, Inc., Phadia US, Inc. engages in the research and development of blood testing products and instrumentation that aid in the diagnosis of allergy. The company is based in Portage, MI. | Health Technology |
| Harvest Time Partners, Inc. | |
Shield Diagnostics Corp.
Shield Diagnostics Corp. Packaged SoftwareTechnology Services Shield Diagnostics Corp. develops advanced genotyping technologies for high throughput and high density testing. It offers beef and dairy cattle. The company was founded by Fred Turner and Sam Parlett and is headquartered in Santa Clara, CA. | Technology Services |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | Technology Services |
